Novel molecular mechanisms inform targeted therapies for chronic kidney disease

A recent study led by Paul DeCaen, Ph.D., associate professor of Pharmacology, has identified novel molecular mechanisms by which genetic mutations in the PKD2 gene cause the most common form of polycystic kidney disease, according to findings published in the Proceedings of the National Academy of Sciences.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup